Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ...

NYU Grossman’s Preeya Mehta, MD, and Jonathan S. Williams, MD, sit down with Mount Sinai’s Louis R. Pasquale, MD, to discuss long-term safety and efficacy data from a PreserFlo microshunt trial and ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.

The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...

Andrew Tatham, MD, MBA, FRCOphth, FEBO, outlines the role of micro-invasive glaucoma surgery alongside established glaucoma ...

At the 2nd International Glaucoma Symposium in Mainz, Germany, on 31 January 2026, optical coherence tomography (OCT) and its role in glaucoma and neuro-ophthalmic disease took centre stage in a ...

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...

Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...

To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...

Wilmer Eye Institute, Johns Hopkins University, ...

For patients for whom surgery is indicated but who are opposed to undergoing glaucoma surgery, he may suggest a different ...